Literature DB >> 8586124

Risk factors for death and hospitalization from pneumonia. A prospective study of a general population.

P Lange1, J Vestbo, J Nyboe.   

Abstract

The aim of this study was to identify possible risk indicators for pneumonia leading to death and hospitalization in the general population. We followed 6,158 men and 7,265 women aged 30-70 years, who participated in the Copenhagen City Heart Study, a prospective population study, for 12 years with regard to mortality and hospital admissions for pneumonia. A total of 260 deaths with pneumonia as main or contributory death cause had occurred, and 405 subjects had been admitted to hospital at least once because of pneumonia. Mortality and hospitalization were analysed by multivariate Cox regression models. In addition to increasing age, forced expiratory volume in one second (FEV1) was strongly and consistently related to both pneumonia related mortality and hospitalization. Women with FEV1 < 60% predicted had a relative risk of 5.7 (95% confidence interval: 2.9-11) and 3.6 (2.1-6.4) for death and hospitalization, respectively, when compared with women with FEV1 > or = 100% predicted. Similar, although lower, relative risks were observed in men. Other significant risk indicators for hospitalization were: self-reported asthma (women), mucus hypersecretion (women and men), history of stroke (men) and smoking (women). We conclude that, in addition to age, reduced FEV1 is the most important risk indicator for severe pneumonia.

Entities:  

Mesh:

Year:  1995        PMID: 8586124     DOI: 10.1183/09031936.95.08101694

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  18 in total

Review 1.  Onset and outcome of asthma in older adults. A clinician's perspective.

Authors:  Charles E Reed
Journal:  Clin Rev Allergy Immunol       Date:  2002-02       Impact factor: 8.667

2.  An exploratory spatial analysis of pneumonia and influenza hospitalizations in Ontario by age and gender.

Authors:  E J Crighton; S J Elliott; R Moineddin; P Kanaroglou; R E G Upshur
Journal:  Epidemiol Infect       Date:  2006-07-07       Impact factor: 2.451

3.  Respiratory symptoms and 30 year mortality from obstructive lung disease and pneumonia.

Authors:  A Frostad; V Soyseth; T Haldorsen; A Andersen; A Gulsvik
Journal:  Thorax       Date:  2006-06-29       Impact factor: 9.139

4.  Prehospital use of inhaled corticosteroids and point prevalence of pneumonia at the time of hospital admission: secondary analysis of a multicenter cohort study.

Authors:  Emir Festic; Vikas Bansal; Ognjen Gajic; Augustine S Lee
Journal:  Mayo Clin Proc       Date:  2014-02       Impact factor: 7.616

5.  Association Between Postextubation Dysphagia and Long-Term Mortality Among Critically Ill Older Adults.

Authors:  Mark Regala; Stevie Marvin; William J Ehlenbach
Journal:  J Am Geriatr Soc       Date:  2019-06-26       Impact factor: 5.562

Review 6.  Recurrent pneumonia: a review with focus on clinical epidemiology and modifiable risk factors in elderly patients.

Authors:  T T Dang; S R Majumdar; T J Marrie; D T Eurich
Journal:  Drugs Aging       Date:  2015-01       Impact factor: 3.923

7.  Past body mass index and risk of mortality among women.

Authors:  S C Moore; S T Mayne; B I Graubard; A Schatzkin; D Albanes; C Schairer; R N Hoover; M F Leitzmann
Journal:  Int J Obes (Lond)       Date:  2008-01-22       Impact factor: 5.095

8.  Obesity and outcomes in patients hospitalized with pneumonia.

Authors:  S Kahlon; D T Eurich; R S Padwal; A Malhotra; J K Minhas-Sandhu; T J Marrie; S R Majumdar
Journal:  Clin Microbiol Infect       Date:  2012-09-11       Impact factor: 8.067

9.  Pneumonia in elderly patients with chronic obstructive pulmonary disease.

Authors:  Pierre Ernst; Samy Suissa
Journal:  Curr Infect Dis Rep       Date:  2008-05       Impact factor: 3.725

10.  Diabetes, glycemic control, and risk of hospitalization with pneumonia: a population-based case-control study.

Authors:  Jette B Kornum; Reimar W Thomsen; Anders Riis; Hans-Henrik Lervang; Henrik C Schønheyder; Henrik T Sørensen
Journal:  Diabetes Care       Date:  2008-05-16       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.